8/16/26
IMPULSE (QINGDAO) HEALTH TECH CO.,LTD. (002899.SZ) Thesis: The recent decline in revenue and net income growth, coupled with increasing competition, has led to a more cautious outlook among investors.
★ Analysts see FY2026 revenue reaching $1.3B — +10.7% growth in a single year.
What Moves the Stock 1 Consumer health trends in China, particularly post-COVID-19 recovery 2 Changes in disposable income affecting consumer spending on leisure products 3 Regulatory changes impacting health and safety standards for fitness equipment 4 Competitive pricing strategies from domestic and international rivals 5 Fitness equipment sales - 70% 6 Health monitoring devices - 20% 7 Accessories and supplements - 10% 8 Health and wellness trend post-pandemic 15.8 21.1 26.5 31.8 37.2 19.74 002899.SZ Daily 19.74 Mar '26 May '26 Jul '26 Aug '26
My Notes "Management noted, 'We are facing significant challenges in maintaining our market share amidst rising competition.'" Moat: Impulse's brand recognition and established distribution channels provide a moderate competitive advantage. value - Investors may be drawn to the stock due to its low valuation metrics despite recent performance struggles. Moderate - Rising interest rates could increase financing costs for expansion and affect consumer borrowing… Watch on earnings: Consumer sentiment index (UMCSENT), Retail sales growth (RSXFS), Gross margin percentage. One Sentence Summary: Impulse (Qingdao) Health Tech Co.,Ltd.: the story is balanced — consumer health trends in china, particularly post-covid-19 recovery.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.